Shepherd Kaplan Krochuk

Trilio specializes in cloud-native data protection, focusing on environments such as Kubernetes, OpenStack, and Red Hat Virtualization. Its flagship technology, TrilioVault, is designed for backup and recovery, workload migration, and application mobility. The platform allows users to restore entire workloads on-demand, providing critical business assurance services for organizations in sectors like telecommunications, defense, automotive, and financial services. TrilioVault supports data protection and migration across various cloud setups, including private, public, and hybrid clouds. This flexibility enables IT organizations and cloud service providers to manage application workloads effectively, ensuring resilience and operational continuity in the face of potential disruptions.

WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. The company develops auto-injectors that are filled with heat-stable epinephrine that enable physicians to inject it into a patient suffering from anaphylaxis due to an acute allergy attack. The company was established in 2011 and is headquartered in Somerville, Massachusetts.

Etiometry is a provider of advanced patient monitoring software designed specifically for hospital ICUs. The company's platform integrates and analyzes healthcare data, allowing clinicians to view comprehensive clinical information on a single screen. This functionality enhances objective communication among care teams and supports the identification of optimal treatment paths for ICU patients. The software consists of three interconnected components that not only deliver critical information for immediate patient care but also assess risk factors associated with deteriorating conditions. Additionally, it archives data for research and quality improvement initiatives, enabling healthcare institutions to gain valuable insights that facilitate the early recognition of subtle changes in patient condition, ultimately aiming to prevent complications and promote faster recovery.

Trilio specializes in cloud-native data protection, focusing on environments such as Kubernetes, OpenStack, and Red Hat Virtualization. Its flagship technology, TrilioVault, is designed for backup and recovery, workload migration, and application mobility. The platform allows users to restore entire workloads on-demand, providing critical business assurance services for organizations in sectors like telecommunications, defense, automotive, and financial services. TrilioVault supports data protection and migration across various cloud setups, including private, public, and hybrid clouds. This flexibility enables IT organizations and cloud service providers to manage application workloads effectively, ensuring resilience and operational continuity in the face of potential disruptions.

NanoDx is a medical device start-up focused on developing portable, easy-to-use, and low-cost handheld products for the screening and monitoring of mild brain injuries, particularly concussions. The company aims to redefine how concussions are identified and managed by offering rapid testing that accurately confirms traumatic brain injuries. These innovative products allow patients who have experienced head trauma to receive timely and appropriate treatment decisions, which may help reduce the need for unnecessary head CT scans. Through its advancements, NanoDx is contributing to improved outcomes in the management of brain injuries.

PCM develops disciplined, rules-based investment strategies designed to evaluate risk on a daily basis and adapt accordingly. PCM also advises high net worth families, pension and profit sharing plans, charitable organizations, and third-party advisors through portfolio management, research, and outsourced chief investment officer capabilities.

WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. The company develops auto-injectors that are filled with heat-stable epinephrine that enable physicians to inject it into a patient suffering from anaphylaxis due to an acute allergy attack. The company was established in 2011 and is headquartered in Somerville, Massachusetts.

EnGeneIC is a bioscience company, develops and commercializes novel concepts in the targeted delivery of chemotherapeutics for cancer drugs in-vivo. The company’s drug/siRNA delivery vehicles offer a range of choices for optimizing the delivery of clinically meaningful drug and siRNA doses to target cancer cells in-vivo. It serves customers in Australia, Singapore, Japan, and India. The company was incorporated in 2000 and is based in Lane Cove West, Australia.